Capital Research Global Investors
BIIB icon

Capital Research Global Investors’s Biogen BIIB Stock Holding History

Capital Research Global Investors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-300,000
Closed -$102M – 443
2014
Q4 		$102M Sell
300,000
-5,156,600
-95% -$1.67B 0.03% 298
2014
Q3 		$1.81B Sell
5,456,600
-2,741,950
-33% -$904M 0.62% 38
2014
Q2 		$2.59B Sell
8,198,550
-345,000
-4% -$104M 0.9% 22
2014
Q1 		$2.61B Sell
8,543,550
-613,450
-7% -$195M 0.94% 17
2013
Q4 		$2.56B Buy
9,157,000
+315,000
+4% +$81.5M 0.95% 20
2013
Q3 		$2.13B Sell
8,842,000
-288,000
-3% -$64.5M 0.84% 28
2013
Q2 		$1.96B Buy
+9,130,000
New +$1.95B 0.84% 26

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Capital Research Global Investors's BIIB Position: Q1 2015 in Review

Capital Research Global Investors sold out of Biogen (BIIB) in Q1 2015, closing a stake of 300,000 shares — an estimated $102M sold.

Capital Research Global Investors first reported a position in BIIB in Q2 2013 and held it in 7 quarters. The position peaked at $2.61B in Q1 2014. 967 funds tracked by Wall St. Rank hold BIIB as of Q1 2015.

  • Capital Research Global Investors reported no remaining Biogen position as of Q1 2015 after selling out during the quarter.
  • Capital Research Global Investors sold 300,000 Biogen shares in Q1 2015, an estimated $102M.
  • Capital Research Global Investors first reported a position in Biogen in Q2 2013 and held it in 7 quarters.
  • Capital Research Global Investors's Biogen position peaked at $2.61B in Q1 2014.
  • 967 funds tracked by Wall St. Rank held Biogen as of Q1 2015.

Based on Capital Research Global Investors's 13F filing for Q1 2015, filed 15 May 2015.